Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
NCLT Cuttack admitted a Section 7 IBC plea against Sun Granite Export over a ₹3.96 crore default, starting a moratorium from August 5, 2026 and appointing an IRP.
Medi Assist reported a 22% YoY rise in Q1 net profit and 24% revenue growth, declared a ₹2 final dividend, and reiterated auditors saw no material impact from an ED probe.
Medi Assist reported Q1FY26 profit of ₹27.60 crore on ₹236.52 crore revenue and set August 8, 2026 for Q1FY27 results approval, followed by an earnings call.
Advanced Enzyme Technologies reported lower Q1 FY27 profit and EBITDA despite a small revenue rise, while its board cleared a buyback, a subsidiary stake buyout, and fund infusion.
Advanced Enzyme Technologies reported softer Q1 FY27 profitability, even as revenue edged up, while the board cleared a ₹69.7 crore open-market buyback and a subsidiary stake purchase.
Prithvi Exchange reported Q1FY27 revenue of ₹1,108.23 crore and net profit of ₹0.71 crore, swinging from a Q4FY26 loss after board approval on August 8, 2026.
Eveready Industries reported Q1FY27 standalone profit of ₹36.96 crore (+22% YoY) on revenue of ₹407.71 crore (+9%), alongside commercial output starting at its Jammu alkaline plant.
Advanced Enzyme Technologies approved a ₹697 million open-market buyback, agreed to acquire JC Biotech’s remaining 4.28% stake, and reported Q1 FY27 results for June 2026.
Captain Pipes reported Q1 FY26 revenue growth to ₹23.68 crore, but consolidated profit dropped to ₹0.75 crore, with the board approving results on 8 August 2026.
Eveready Industries posted a 22% YoY rise in Q1FY27 profit to ₹36.96 crore on ₹407.71 crore revenue, while beginning commercial production at its Jammu alkaline battery unit.
NCLT New Delhi reserved its order in a Section 7 CIRP matter against AF Enterprises in June 2025, but the company received and disclosed it in June 2026.
Advanced Enzyme reported softer Q1 FY27 profitability, approved a ₹69.7 crore open-market buyback, and cleared steps to make JC Biotech a wholly owned subsidiary.
Metroglobal reported Q1FY27 consolidated net profit of ₹4.96 crore on revenue from operations of ₹81.30 crore, with earnings aided by a ₹3.96 crore tax refund.
Eveready Industries reported Q1FY27 profit growth and higher revenue, while flagging the start of commercial production at its new Jammu alkaline battery manufacturing facility.
Eveready Industries posted Q1FY27 profit of ₹36.96 crore on revenue of ₹407.71 crore, as the board approved results and commercial production began at Jammu’s alkaline battery facility.
Retail interest in India’s T-Bill auctions is rising, and investors are sharing practical rules on minimum bids, oversubscription, and how non-competitive allotment is decided.
